Potensi Antivirus dari Bakteri Asam Laktat
Kata Kunci:
Lactic Acid Bacteria, antiviral agents, bacteriocinsAbstrak
Viruses mutate and evolve very rapidly, antiviral agent resistance is emerging as a growing public health problem around the world. The demand for new antiviral agents is increasing as a potential source of new drugs and alternative drugs that are currently being used. Various literature describes the potential of lactic acid bacteria (LAB) and bacteriocins as antiviral agents. LAB probiotics can promote health for the human body by (1) direct probiotic-virus interactions; (2) production of antiviral inhibiting metabolites; and / or (3) through stimulation of the immune system. The purpose of this article is to examine the potential for LAB that produce antiviral activity.
Referensi
Ayivi, Raphael & Ibrahim, Salam & Gyawali, Rabin & Krastanov, Albert & Tahergorabi, Reza & Aljaloud, Sulaiman & Worku, Mulumebet & Silva, Roberta. “Lactic Acid Bacteria: Food Safety and Human Health Applications”. Dairy. 1. 2020.
Y. Yang , H. Song, W. Li , W. Dong and Z. Yang. “Antiviral Effects of a Probiotic Metabolic Products against Transmissible Gastroenteritis Coronavirus”. Journal of Probiotics & Health, vol. 5, no. 3, p. 6p, 2017.
FAO/WHO (2002) Joint working group report on guidelines for the evaluation of probiotics in food. London, Ontario, Canada
Liu SQ. “Practical implications of lactate and pyruvate metabolism by lactic acid bacteria in food and beverage fermentations”. Int J Food Microbiol 83:115–131. 2003.
Al Kassaa I, Hober D, Hamze M, Chihib NE, Drider D. Antiviral potential of lactic acid bacteria and their bacteriocins. “Probiotics Antimicrob Proteins”. Vol. 6(3-4), pp. 177-185. 2014. doi: 10.1007/s12602-014-9162-6. PMID: 24880436.
Biliavska, Liubov et al. “Antiviral Activity of Exopolysaccharides Produced by Lactic Acid Bacteria of the Genera Pediococcus, Leuconostoc and Lactobacillus against Human Adenovirus Type 5.” Medicina (Kaunas, Lithuania) vol. 55,9 519. 22 Aug. 2019, doi:10.3390/medicina55090519
Villena J, Oliveira ML, Ferreira P, Salva S, Alvarez S. “Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges”. Int Immunopharmacol, 11:1633–1645. 2011
Harzallah D, Belhadj H. “Lactic acid bacteria as probiotics: characteristics, selection criteria and role in immunomodulation of human GI muccosal barrier”. Chapter 8. Book: 198 Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes, 2013. Inteck edition
Lakshmi B, Viswanath B, Sai Gopal DV (2013) Probiotics as antiviral agents in shrimp aquaculture. J Pathog 2013:424123. doi:10.1155/2013/424123
Seo BJ, Rather IA, Kumar VJ, Choi UH, Moon MR, Lim JH, Park YH. “Evaluation of Leuconostoc mesenteroides YML003 as a probiotic against low-pathogenic avian influenza (H9N2) virus in chickens”. J Appl Microbiol.vol 113, pp163–17. 2013.
Botic´ T, Klingberg TD, Weingartl H et al (2007) A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol 115:227–234
. Wang Z, Chai W, Burwinkel M, Twardziok S, Wrede P, Palissa C, Esch B, Schmid MFG (2013) Inhibitory influence of Enterococcus faecium on the propagation of swine influenza a virus in vitro. PLoS One 8:e53043
. Al Kassaa I, Hamze M, Hober D et al (2014) Identification of vaginal lactobacilli with potential probiotic properties isolated from women in North Lebanon. Microb Ecol 67:722–734
Mastromarino P, Cacciotti F, Masci A, Mosca L (2011) Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe 17:334–336
. Kawashima T, Kyoko H, Akemi K, Megumi K et al (2011) Lactobacillus plantarum strain YU from fermented foods.
Maeda N, Nakamura R, Hirose Y, Murosaki S, Yamamoto Y, Kase T, Yoshikai Y (2009) Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol 9:1122–1125
. Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27:5677–5684
. Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, Rodriguez JM, Xaus J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23:254–260
. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J (2006) Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24:6670–6674
. Rautava S, Salminen S, Isolauri E (2009) Specific probiotics in reducing the risk of acute infections in infancy a randomised, double-blind, placebo-controlled study. Br J Nutr 101:1722–1726
. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124:e172–e179
. Chiba E, Tomosada Y, Guadalupe MVP, Salva S (2013) Immunobiotic Lactobacillus rhamnosus improves resistance of infantmice against respiratory syncytial virus infection. Int Immunopharmacol 17:373–382
Salva S, Nun˜ez M, Villena J, Ramo´n A, Font G, Alvarez S (2011) Development of a fermented goats’ milk containing Lactobacillus rhamnosus: in vivo study of health benefits. J Sci Food Agric 91:2355–2362
Yasui H, Kiyoshima J, Hori T (2004) Reduction of influenzavvirus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn LabvImmunol 11:675–679
Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E,vCencic A (2010) Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from entericvvirus infection. Int J Food Microbiol 141:S91–S97
Kiso M, Takano R, Sakabe S, Katsura K, Shinya K, Uraki R (2013) Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus. Sci Rep 3:1563
Sarker SA, Sultana S, Fuchs GJ, Alam NH, Azim T, Brussow H, Hammarstrom L (2005) Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotaviru s diarrhea in children from Bangladesh. Pediatrics 116:e221–e228
Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E, Cencic A (2010) Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. Int J Food Microbiol 141:S91–S97
Cha MK, Lee DK, An HM, Lee SW, Shin SH, Kwon JH, Kim KJ, Ha NJ (2012) Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Med 10:72
Khania S, Motamedifara M, Golmoghaddam H, Hosseinic HM, Hashemizadeha Z (2012) In vitro study of the effect of a probiotic bacterium Lactobacillus rhamnosus against herpes simplex virus type 1. Braz J Infect Dis 16:129–135
Martin V, Maldonado A, Fernandez L, Rodriguez JM, Connor RI (2010) Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk. Breastfeed Med 5:153–158
Klebanoff SJ, Coombs RW (1991) Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 174:289–292
Conti C, Malacrino C, Mastromarino P (2009) Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 6:19–26
Martin LS, McDougal JS, Loskoski SL (1985) Disinfection and inactivation of the human lymphotropic virus type III/lymphadenopathy- associated virus. J Infect Dis 152:400–403
Tuyama AC, Cheshenko N, Carlucci MJ, Li JH, Goldberg CL, Waller DP, Anderson RA, Profy AT, Klotman ME, Keller MJ, Herold BC (2006) Acidform inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. J Infect Dis 194:795–803
Mastromarino P, Cacciotti F, Masci A, Mosca L (2011) Antiviralactivity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe 17:334–336
Hill JA, Anderson DJ (1992) Human vaginal leukocytes and the effects of vaginal fluid lymphocyte and macrophage defense functions. Am J Obstet Gynecol 166:720–726.
Ennahar S, Sashihara T, Sonomoto K, Ishizaki A (2000) Class Iia bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 24:85–106
Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12:39–86
Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3:777–788
Abee T (1995) Pore-forming bacteriocins of Gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol Lett 129:1–10
Abee T, Krockel L, Hill C (1995) Bacteriocins: modes of action and potentials in food preservation and control of food poisoning.Int J Food Microbiol 28:169–185
Moll GN, Konings WN, Driessen AJM (1999) Bacteriocins: mechanism of membrane insertion and pore formation. Antonie Van Leeuwenhoek 76:185–198
Drider D, Rebuffat S (2011) Prokaryotic antimicrobial peptides: fromgenes to applications. Springer, New York, ISBN 9781441976918
Humaira Q, Sadia S, Ahmed S, Ajaz Rasool S (2006) Coliphage hsa as a model for antiviral studies/spectrum by some indigenousbacteriocin like inhibitory substances (BLIS). Pak J Pharma Sci 19:182–187
. Saeed S, Rasool RA, Ahmad S, Zaidi SZ, Rehmani S (2007) Antiviral activity of Staphylococcin 188: a purified bacteriocinlike inhibitory substance isolated from Staphylococcus aureus AB188. Res J Microbiol 2:796–806
Todorov SD, Wachsman MB, Knoetze H, Meincken M, Dicks LMT (2005) An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans. Int J Antimicrob Agents 25:508–513
Todorov SD, Wachsman M, Tome´ E, Dousset X, Destro MT, Dicks LM, Franco BD, Vaz-Velho M, Drider D (2010) Characterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium. Food Microbiol 27:869–879
Wachsman MB, Farias ME, Takeda E, Sesma F, De Ruiz HolgadoAP, de Torres RA, Coto CE (1999) Antiviral activity of enterocin CRL against herpes virus. Int J Antimicrob Agents12:293–299.
Jounai K, Sugimura T, Ohshio K, Fujiwara D. Oral administration of Lactococcus lactis subsp. lactis JCM5805 enhances lung immune response resulting in protection from murine parainfluenza virus infection. PLoS One 2015; 10: e0119055.
Trinchieri G, Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 1978; 147: 1314-33.
Guo Z, Tilburgs T, Wong B, Strominger JL. Dysfunction of dendritic cells in aged C57BL/6 mice leads to failure of natural killer cell activation and of tumor eradication. Proc Natl Acad Sci U S A 2014; 111: 14199-204.
Suzuki H, Ohshio K, Fujiwara D. Lactococcus lactis subsp. lactisJCM 5805 activates natural killer cells via dendritic cells. Biosci Biotechnol Biochem 2016; 80: 798-800.
Lee CK, Rao DT, Gertner R, et al. Distinct requirements for IFNsand STAT1 in NK cell function. J Immunol 2000; 165: 3571-7.
Gerosa F, Gobbi A, Zorzi P, et al. The reciprocal interaction of NKcells with plasmacytoid or myeloid dendritic cells profoundly affectsinnate resistance functions. J Immunol 2005; 174: 727-34.
Salminen S, Nybom S, Meriluoto J, et al. Interaction of probioticsand pathogens--benefits to human health? Curr Opin Biotechnol 2010; 21: 157-67.
Kanauchi O, Andoh A, AbuBakar S, Yamamoto N. Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems. Curr Pharm Des. 2018;24(6):710-717. doi: 10.2174/1381612824666180116163411. PMID: 29345577; PMCID: PMC6006794.
Sugimura T, Jounai K, Ohshio K, et al. Immunomodulatory effect of Lactococcus lactis JCM5805 on human plasmacytoid dendritic cells. Clin Immunol 2013; 149: 509-18.
